FDA Halts Rocket’s Gene Therapy Trial After FatalityFDARocket Pharmaceuticals faces an FDA clinical hold on its gene therapy trial for Danon disease following a patient death. The company is reassessing its approach and extending its financial runway into 2027.
EN
Agricultural News
Food News
Industrial News
Cosmetic News
Pharmaceutical News
Science News
